| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/15/1993 | DE4133694A1 Verwendung einer emulsion, zur herstellung eines arzneimittels zur iv-verabreichung zur behandlung von hauterkrankungen Use of an emulsion, for the manufacture of a medicament for intravenous administration for the treatment of skin diseases |
| 04/15/1993 | CA2120756A1 Pyridinol derivatives as medicaments |
| 04/15/1993 | CA2120328A1 Purified chitin deacetylase |
| 04/14/1993 | EP0536817A1 Azabicyclic compounds as tachykinin antagonists |
| 04/14/1993 | EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/14/1993 | EP0536186A1 Bone and cartilage inductive proteins |
| 04/13/1993 | US5202313 Bilobalide derivatives, their applications and formulations containing them |
| 04/13/1993 | CA1316132C Cdna and gene for human angiogenin (angiogenesis factor) and method of expression |
| 04/07/1993 | EP0535327A1 Pharmaceutical composition containing felbinac |
| 04/07/1993 | CN1070574A Low molecular weight vegetable composition |
| 04/06/1993 | US5200550 Administering for dermatologic, rheumatismal, respiratory or ophthalomologic disorders |
| 04/06/1993 | US5200429 Acne vulgaris treating |
| 04/06/1993 | US5200397 Administering an oligopeptides anticoagulants or wound healing agents |
| 04/06/1993 | CA1315803C N-alkoxyalkylamides of hydroxyacids and skin treating compositions therewith |
| 04/06/1993 | CA1315774C Anthraline-sterol complexes, their production process and their use as therapeutics and cosmetics |
| 04/06/1993 | CA1315686C Pharmaceutical compositions containing at least one naphtylaromatic compound as an active ingredient |
| 04/06/1993 | CA1315685C Pharmaceutical compositions based on benzoic benzopyranyl and benzothiopyranyl compounds |
| 04/06/1993 | CA1315674C Pharmaceutical compositions containing at least one bicyclic aromatic derivative as an active ingredient |
| 04/02/1993 | CA2079420A1 Pharmaceutical composition containing felbinac |
| 04/01/1993 | WO1993006086A1 Retinoids and their use in treating skin diseases and leukemia |
| 04/01/1993 | WO1993006085A1 Pyridine compounds for treating leukotriene-related diseases |
| 04/01/1993 | WO1993005795A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds |
| 04/01/1993 | WO1993005752A1 Cosmetic and dermatological preparations |
| 04/01/1993 | DE4131940A1 Kosmetische und dermatologische zubereitungen Cosmetic and dermatological preparations |
| 04/01/1993 | CA2119571A1 Retinoids and their use in treating skin diseases and leukemia |
| 04/01/1993 | CA2119467A1 Pyridine compounds for treating leukotriene-related diseases |
| 03/31/1993 | EP0534568A2 Human growth hormone analogues and their use |
| 03/31/1993 | EP0534343A1 Substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo(b) thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments |
| 03/31/1993 | EP0534310A1 Combination containing growth factors and polyelectrolytes |
| 03/31/1993 | EP0533865A1 Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them |
| 03/31/1993 | EP0533820A1 Pharmaceutical preparation. |
| 03/31/1993 | EP0479799A4 Wound healing |
| 03/31/1993 | EP0265514B1 Medicaments for inhibiting skin wrinkling |
| 03/30/1993 | US5198567 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them |
| 03/30/1993 | US5198460 Pyropheophorbides and their use in photodynamic therapy |
| 03/30/1993 | CA1315201C Pharmaceutical compounds based on benzamido aromatic compounds |
| 03/27/1993 | CA2079042A1 Combination containing growth factors and polyelectrolytes |
| 03/24/1993 | EP0533433A1 Use of rapamycin for the manufacture of a medicament for the treatment of immunoinflammatory diseases |
| 03/24/1993 | EP0533408A2 Cosmetics and pharmaceuticals containing extensins |
| 03/24/1993 | EP0533213A1 Use of azelastin and glycerine ethers for the treatment of psoriasis |
| 03/24/1993 | EP0353273B1 An anti-inflammatory oxidizing agent, the procedure for its production and various applications |
| 03/24/1993 | CA2078712A1 Composition comprising amino acids for the prevention of hypoxic damage and a process for its preparation |
| 03/23/1993 | US5196411 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors |
| 03/23/1993 | US5196185 Collagen-based wound dressing and method for applying same |
| 03/23/1993 | CA1314906C Didehydro vitamin d -derivatives |
| 03/23/1993 | CA1314891C Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid like activity |
| 03/23/1993 | CA1314884C 2,4-diaminopyrimidine derivatives and oxothiamorpholinecarboxylic acid salts; their use in cosmetics and pharmaceutical compositions |
| 03/23/1993 | CA1314874C Etretinic type or related esters of macrolidic and lincosamidic antibiotics, process for their preparation and pharmaceutical and cosmetical compositions containing them |
| 03/19/1993 | EP0574383A4 Color modified melanins and methods for their preparation and use. |
| 03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
| 03/18/1993 | WO1993005045A1 Spirocyclic benzopyran imidazolines |
| 03/18/1993 | WO1993005019A1 Indole derivatives as 5-alpha-reductase inhibitor |
| 03/18/1993 | WO1993004691A1 Compositions and methods for treating wounds |
| 03/18/1993 | WO1993004680A1 Macrocyclic immunomodulators |
| 03/18/1993 | CA2118697A1 Indole derivatives as 5-alpha-reductase inhibitor |
| 03/18/1993 | CA2116958A1 Cosmetic or pharmaceutical composition containing an extract of coleus esquirolii, coleus scutellarioides or coleus xanthanthus |
| 03/18/1993 | CA2116549A1 Compositions and methods for treating wounds |
| 03/18/1993 | CA2113818A1 Spirocyclic benzopyran imidazolines |
| 03/17/1993 | EP0532465A1 Protein fraction for cosmetic and dermatological care of the skin |
| 03/17/1993 | EP0532190A2 Benzo f quinolinones as 5-alpha-reductase inhibitors |
| 03/17/1993 | EP0532091A1 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)-phenyl)-5-methyl-3H-1,2,4-triazol-3-one derivatives as 5-lipoxygenase inhibitors |
| 03/17/1993 | EP0532027A1 Cyclic nitrones, their preparation and pharmaceutical compositions containing them |
| 03/17/1993 | EP0531598A1 1,4-Dihydropyridines with paf-antagonistic activity |
| 03/16/1993 | US5194614 Antiischemic agents, analgesics, immunology, sedatives or hypoglycemic agents |
| 03/16/1993 | US5194596 Production of vascular endothelial cell growth factor |
| 03/16/1993 | US5194259 Plant extracts |
| 03/16/1993 | US5194247 Synergistic skin depigmentation composition |
| 03/14/1993 | CA2076257A1 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives |
| 03/14/1993 | CA2051350A1 Micro-organism and proteases therefrom |
| 03/10/1993 | EP0531219A1 Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs |
| 03/10/1993 | EP0531080A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein |
| 03/10/1993 | EP0530861A2 Topical antimicrobial pharmaceutical compositions |
| 03/10/1993 | EP0447414B1 Use of minoxidil for wound healing |
| 03/10/1993 | EP0365519B1 Topical prodrugs for treatment of acne and skin diseases |
| 03/10/1993 | EP0341302B1 Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
| 03/10/1993 | CA2074419A1 1,4-dihydropyridines with paf-antagonistic activity |
| 03/09/1993 | US5192544 Cosmetic or pharmaceutical composition for topical application containing at least one retinoid derivative and at least one pyrimidine derivative, its use as a medicinal product and corresponding treatment process |
| 03/09/1993 | CA1314218C Remote administration of hyaluronic acid to mammals |
| 03/06/1993 | WO1993004679A1 Macrocyclic immunomodulators |
| 03/06/1993 | CA2103453A1 Macrocyclic immunomodulators |
| 03/05/1993 | CA2077322A1 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 03/04/1993 | WO1993004056A1 New leukotriene-b4 antagonists, methods of preparing them and their use as drugs |
| 03/04/1993 | WO1993003746A1 Preparation of medicaments containing the peptidoglycan monomer or its derivatives |
| 03/04/1993 | WO1993003713A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 03/04/1993 | CA2115270A1 The use of the peptidoglycan monomer (pgm), its n-acyl derivatives, and its metal complexes in the preparation of medicaments for the correction of the immunosuppressive and hepatosuppressive states of the organism |
| 03/04/1993 | CA2114951A1 New leukotriene-b antagonists, methods of preparing them and their use as drugs |
| 03/03/1993 | EP0530087A1 Naphthylethylurea and naphthylethylthiourea compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/03/1993 | EP0530060A1 Medication based on neutralised sulphur derivatives |
| 03/03/1993 | EP0529848A1 Alkylmethylsiloxane mixtures for skin care |
| 03/03/1993 | EP0529749A1 Leukotriene-B4-antagonists, method for their preparation, and their use as medicaments |
| 03/03/1993 | EP0364442B1 Therapeutical compositions against psoriasis |
| 03/03/1993 | EP0165970B1 Hair growth modification |
| 03/03/1993 | CA2076699A1 Compositions for topical treatment of psoriasis and atopic dermatitis |
| 03/02/1993 | US5190935 Vitamin d analogues |
| 03/02/1993 | US5190758 Sebaceous excitosecretory agent |
| 02/25/1993 | DE4224781A1 (alpha)-glycosylquercetine, verfahren zu ihrer herstellung und ihre verwendung (Alpha) -glycosylquercetine, processes for their preparation and their use |
| 02/24/1993 | EP0528485A1 17Beta-acyl-3-androsta-3,5-dienes as testosterone 5alpha-reductase inhibitors |
| 02/24/1993 | EP0527764A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/23/1993 | US5189178 Preventing protein destruction |
| 02/23/1993 | US5189149 High concentration, solvent-free |